Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daily Adaptive Post-Prostatectomy Radiation With Stereotactic Ablative Radiotherapy (DAPPER)

NCT05830838 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05830838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05830838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daily Adaptive Post-Prostatectomy Radiation With Stereotactic Ablative Radiotherapy (DAPPER)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 28, 2023
Completion date
May 30, 2029
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant prostate neoplasm